Holen Sie sich die Stockscreener-App
11.67
0.26%
-0.03
Handel nachbörslich:
11.72
0.05
+0.43%
Schlusskurs vom Vortag:
$11.70
Offen:
$11.7577
24-Stunden-Volumen:
1,105
Relative Volume:
0.31
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.61%
1M Leistung:
-7.79%
6M Leistung:
-25.10%
1J Leistung:
-13.75%
1-Tages-Spanne:
$11.67
$11.76
1-Wochen-Bereich:
$11.38
$11.98
52-Wochen-Spanne:
$11.38
$17.96
Range Cancer Therapeutics Etf Stock (CNCR) Company Profile
Firmenname
Range Cancer Therapeutics Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CNCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNCR
Range Cancer Therapeutics Etf
|
11.67 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
296.20 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
597.58 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
600.26 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
521.74 | 124.43B | 0 | 0 | 0 | 0.00 |
Range Cancer Therapeutics Etf Aktie (CNCR) Neueste Nachrichten
NEW: The Most Popular Sponsored Content of 2024 - Visual Capitalist
Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail
(CNCR) Investment Analysis - Stock Traders Daily
7 Best-Performing Biotech ETFs for January 2025 - NerdWallet
Total World Stock Index ETF Vanguard (VT-A) QuotePress Release - The Globe and Mail
Chevron Corp (CVX-N) QuotePress Release - The Globe and Mail
Texas Instruments (TXN-Q) QuotePress Release - The Globe and Mail
Pfizer Inc (PFE-N) QuotePress Release - The Globe and Mail
When the Price of (CNCR) Talks, People Listen - Stock Traders Daily
Cutaneous T-Cell Lymphoma Diagnosis Market Set to Surpass US$ 425.8 Million by 2034, States Fact.MR - GlobeNewswire Inc.
(CNCR) Trading Report - Stock Traders Daily
Enbridge Inc (ENB-N) QuotePress Release - The Globe and Mail
Cold Spring Harbor Laboratory - TBR News Media
Regeneron Pharmaceuticals, Inc. (REGN): Among the Most Promising Cancer Stocks According to Hedge Funds - MSN
Daniel Dunaief - TBR News Media
10 Most Promising Cancer Stocks According to Hedge Funds - Insider Monkey
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
CSHL and Range ETFs launch new partnership - Cold Spring Harbor Laboratory
(CNCR) Long Term Investment Analysis - Stock Traders Daily
Trackinsight ETF data from 11th to 15th November, 2024 - ETF Express
The Best Biotech Stocks to Buy - Morningstar
Charted: Cancer Survival Rates Over Time - Visual Capitalist
Range Cancer Therapeutics - TBR News Media
How this award-winning TV host is setting the stage to help protect her health - TBR News Media
Investment fund pledges revenues in cancer research partnership with CSHL - TBR News Media
(CNCR) Trading Signals - Stock Traders Daily
At a Glance: Nov. 6 - Crain's New York Business
The 5 Best Biotech ETFs of 2024 - TradingView
Seagen’s Ex-CEO Starts Company to Develop Drug Tackling Wide Range of Cancers - BNN Bloomberg
SPDR Galaxy Hedged Digital Asset Ecosystem ETF (HECO-Q) QuotePress Release - The Globe and Mail
Microsoft Corp (MSFT-Q) QuotePress Release - The Globe and Mail
Science & Technology - TBR News Media
(CNCR) Investment Report - Stock Traders Daily
How are ADC drug partnerships changing China’s biotech landscape? - Invesco
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Investing News Network
4 Cancer Stocks to Consider in 2024 - The Motley Fool
The Zacks Analyst Blog SFYX, CNCR, FXN and DIV - Yahoo Finance
4 Solid ETFs Under $20 for Your Portfolio - Yahoo Finance
Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market (SMMT) - Seeking Alpha
Trackinsight ETF data from 23rd to 27th September, 2024 - ETF Express
(CNCR) Investment Analysis and Advice - Stock Traders Daily
Breaking Down Acrivon: Deep Dive Into Revenue, Profitability, And Prospects (NASDAQ:ACRV) - Seeking Alpha
7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money
Roundhill Investments Surpasses $2 Billion AUM Milestone – Company Announcement - Financial Times
5 ETFs That Led the Rebound on Monday - Yahoo Finance
IPO Roundup: Bicara Therapeutics, Kairos Pharma and more (NYSEARCA:IPO) - Seeking Alpha
Trading (CNCR) With Integrated Risk Controls - Stock Traders Daily
Cellectis: Cheap With Promising But Speculative Cancer Therapies (NASDAQ:CLLS) - Seeking Alpha
Best-Performing ETF Areas of Past Week - MSN
Finanzdaten der Range Cancer Therapeutics Etf-Aktie (CNCR)
Es liegen keine Finanzdaten für Range Cancer Therapeutics Etf (CNCR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):